2018 and Beyond: Hungary Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Hungary witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Hungary and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Hungary healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Hungary healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Hungary pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Hungary and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Hungary healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Hungary healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Hungary pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Hungary Pharmaceutical and Healthcare Industry Snapshot
2.2 Hungary Pharmaceuticals Market Overview
3 HUNGARY PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Hungary
3.2 Drivers and Restraints
3.2.1 Market Drivers in Hungary Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Hungary Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 HUNGARY PHARMACEUTICAL MARKET OUTLOOK
4.1 Hungary Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Hungary Pharmaceutical Exports, $ million, 2015- 2025
4.3 Hungary Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Hungary (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Hungary (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Hungary Prescription Drug Sales, $ Million, 2015- 2025
4.7 Hungary Generic Drug Sales, $ Million, 2015- 2025
5 HUNGARY HEALTHCARE MARKET OUTLOOK
5.1 Hungary Healthcare Expenditure Outlook, 2015- 2025
5.2 Hungary Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Hungary Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Hungary Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Hungary, 2015- 2025
6 HUNGARY HEALTHCARE MARKET STATISTICS
6.1 Hungary Mortality by Disease Category, 2017
6.2 Number of Hospitals in Hungary, 2007- 2017
6.3 Number of Hospital Beds in Hungary, 2007- 2017
6.4 Physicians Count in Hungary, 2007- 2017
6.5 Pharmacists Count in Hungary, 2007- 2017
7 HUNGARY CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Hungary, 2017
7.2 Ongoing Clinical Trials by Disease Category in Hungary, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 HUNGARY DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Hungary Population Forecast by Age Group, 2005- 2025
8.2 Hungary Population Forecast by Location, 2005- 2025
8.3 Hungary GDP Forecast, 2005- 2025
8.4 Hungary GDP Per Capita Forecast, 2005- 2025
8.5 Hungary Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN HUNGARY PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Hungary Pharmaceutical and Healthcare Industry Snapshot
2.2 Hungary Pharmaceuticals Market Overview
3 HUNGARY PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Hungary
3.2 Drivers and Restraints
3.2.1 Market Drivers in Hungary Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Hungary Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 HUNGARY PHARMACEUTICAL MARKET OUTLOOK
4.1 Hungary Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Hungary Pharmaceutical Exports, $ million, 2015- 2025
4.3 Hungary Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Hungary (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Hungary (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Hungary Prescription Drug Sales, $ Million, 2015- 2025
4.7 Hungary Generic Drug Sales, $ Million, 2015- 2025
5 HUNGARY HEALTHCARE MARKET OUTLOOK
5.1 Hungary Healthcare Expenditure Outlook, 2015- 2025
5.2 Hungary Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Hungary Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Hungary Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Hungary, 2015- 2025
6 HUNGARY HEALTHCARE MARKET STATISTICS
6.1 Hungary Mortality by Disease Category, 2017
6.2 Number of Hospitals in Hungary, 2007- 2017
6.3 Number of Hospital Beds in Hungary, 2007- 2017
6.4 Physicians Count in Hungary, 2007- 2017
6.5 Pharmacists Count in Hungary, 2007- 2017
7 HUNGARY CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Hungary, 2017
7.2 Ongoing Clinical Trials by Disease Category in Hungary, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 HUNGARY DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Hungary Population Forecast by Age Group, 2005- 2025
8.2 Hungary Population Forecast by Location, 2005- 2025
8.3 Hungary GDP Forecast, 2005- 2025
8.4 Hungary GDP Per Capita Forecast, 2005- 2025
8.5 Hungary Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN HUNGARY PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
